These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11115733)

  • 41. [Dynamics of integral parameters of the background EEG during treatment with neuroleptics].
    Bochkarev VK; Paniushkina SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):258-64. PubMed ID: 6122319
    [No Abstract]   [Full Text] [Related]  

  • 42. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
    Lapierre YD; Nair NP; Chouinard G; Awad AG; Saxena B; Jones B; McClure DJ; Bakish D; Max P; Manchanda R
    Acta Psychiatr Scand Suppl; 1990; 358():72-7. PubMed ID: 1978496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiosyncratic neuroleptic response.
    Harrop DS
    J Clin Psychiatry; 1987 Aug; 48(8):344-5. PubMed ID: 2886492
    [No Abstract]   [Full Text] [Related]  

  • 45. Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
    Zedkova I; Dudova I; Urbanek T; Hrdlicka M
    Neuro Endocrinol Lett; 2011; 32(5):667-70. PubMed ID: 22167144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and tolerance of risperidone in various doses (report of a study)].
    Cesková E; Svestka J
    Ceska Slov Psychiatr; 1996 Feb; 92(1):50-6. PubMed ID: 8768938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
    Svestka J; Cesková E; Rysánek R; Náhunek K
    Act Nerv Super (Praha); 1989 Dec; 31(4):276-7. PubMed ID: 2576922
    [No Abstract]   [Full Text] [Related]  

  • 50. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.
    Blin O; Azorin JM; Bouhours P
    J Clin Psychopharmacol; 1996 Feb; 16(1):38-44. PubMed ID: 8834417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.
    Rosenheck RA; Leslie DL; Sindelar J; Miller EA; Lin H; Stroup TS; McEvoy J; Davis SM; Keefe RS; Swartz M; Perkins DO; Hsiao JK; Lieberman J;
    Am J Psychiatry; 2006 Dec; 163(12):2080-9. PubMed ID: 17151158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antipsychotic drug effects on brain morphology in first-episode psychosis.
    Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
    Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.
    Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
    J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine.
    Anand R; Geffen Y; Vasile D; Dan I
    Clin Neuropharmacol; 2010; 33(6):297-302. PubMed ID: 20921890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risperidone in the treatment of schizophrenia.
    Marder SR; Meibach RC
    Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients.
    Shiloh R; Schapir L; Bar-Ziv D; Stryjer R; Konas S; Louis R; Hermesh H; Munitz H; Weizman A; Valevski A
    Eur Neuropsychopharmacol; 2009 Sep; 19(9):654-8. PubMed ID: 19493658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia.
    Schmitt A; Maras A; Petroianu G; Braus DF; Scheuer L; Gattaz WF
    J Neural Transm (Vienna); 2001; 108(8-9):1081-91. PubMed ID: 11716143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.